Navigation auf uzh.ch
Navigation auf uzh.ch
In today’s rapidly evolving digital landscape, AI and other emerging technologies are transforming industries, including healthcare and pharma, by offering innovative capabilities and enhanced efficiency. However, the rise of AI brings new ethical challenges beyond traditional concerns of security and data protection.
In this session, the DSI Community Ethics will explore the importance of AI ethics within the pharma and life sciences sectors, focusing on practical strategies to mitigate risks while ensuring AI-driven innovation. It will be examined how a market-oriented approach can be combined with regulatory frameworks to address these concerns responsibly. Additionally, the key findings from an Innosuisse-funded study, conducted in collaboration with the University of Zurich and MQ Academy, on AI ethics in pharma and life sciences will be presented.
When / Wann: December 4, 2024, 17:00 - 19:00
Where / Wo: Digital Society Initiative, Rämistrasse 69, 8001 Zurich
Language / Sprache: English
Registration / Anmeldung: Link
Organisation: DSI Community Ethics
|
17:00 - 17:10 |
Welcome |
| 17:10 - 17:40 | Innocheque study results Ethical Decision Making Intelligence for Healthcare by Deepak Bansal (Founder, MQ Learning Academy), Michele Loi (Independent Consultant) (via Zoom), and Christian H. Hoffmann, will present the findings of an Innosuisse-funded research study on the critical role of AI ethics in healthcare. The presentation will highlight the study’s insights into the need for ethical frameworks in AI applications within healthcare and the essential role that education can play in fostering ethical decision making |
| 17:40 - 17:50 | Q&A |
| 17:50 - 18:10 |
Implementing Ethical AI at Roche byDr. Katrina Bremstedt (Global Head of Bioethics) will provide an overview of the work her team is doing to implement Ethical AI at Roche. She will discuss the significance of Ethical AI for the pharmaceutical industry, particularly for Roche, and explain how it differs from Responsible AI. Additionally, Dr. Bremstedt will outline the specific practices and initiatives Roche is undertaking to ensure the integration of Ethical AI principles. |
| 18:10 - 18:20 | Q&A |
| 18:20 - 18:40 | Turning AI Ethics into Action: The Challenges of Responsible AI (RAI) for consultancies and their clients by Dr. Eleonora Viganò (University of Zurich and University of Applied Sciences of the Grisons), will share findings from the Innossuisse IB Databooster project on the implementation of RAI in Swiss companies. Drawing on insights from 11 interviews with consultancies, their clients, and RAI experts and a workshop in partnership with six Swiss companies, she will offer an overview of the main pains and gains companies experience with RAI implementation. She will also outline the initial solutions proposed to help organizations overcome these challenges. The presentation will focus on the gap between the numerous high-level RAI frameworks available and the difficulties companies face in applying these frameworks within their workflows and adapting them to their specific industries, sectors, and departments. |
| 18:40 - 18:50 | Q&A |
| 18:50 - 19:15 | Discussion |
